Goldman Sachs notes modest earnings upside for IBM and Cognizant ahead of Q1 results, rating IBM buy and Cognizant neutral.
Analyst cites resilient software momentum at IBM despite mainframe slowdown and a strong backlog at Cognizant supporting near‑term outperformance.
Globant faces downside risk due to exposure to Media & Entertainment and Middle East conflict, with AI Pods unlikely to offset headwinds.
Goldman highlights demand commentary and AI adoption updates as key focus this quarter amid rising macro uncertainty globally.